Key Metrics
CiteScore 

3.2
Impact Factor 

10 - 15
SNIP 

0.67
Recommended pre-submission checks
Powered by 

Topics Covered on Clinical and Experimental Hypertension
Clinical and Experimental Hypertension Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS INC |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | GBP 1880 | USD 2390 | EUR 2180 | AUD 3265 |
| Publication Time | 7 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1978 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Clinical and Experimental Hypertension ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical and Experimental Hypertension
Synergistic impact of nondipper heart rate and blood pressure on left ventricular hypertrophy in essential hypertension
- 31 Dec 2026
- Clinical and Experimental Hypertension
Dissecting burden of alcoholic cardiomyopathy: age-period-cohort analysis from the global burden of disease study 2019
- 31 Dec 2026
- Clinical and Experimental Hypertension
Frailty as a mediator of the association between hyperuricemia and stroke risk: A prospective cohort study.
- 31 Dec 2026
- Clinical and experimental hypertension (New York, N.Y. : 1993)
Bulk and single-cell transcriptomics for identification of potential diagnostic biomarkers associated with pulmonary arterial hypertension and integrated stress response and experimental validation
- 31 Dec 2026
- Clinical and Experimental Hypertension
Elevated circulating unsaturated fatty acids: A novel metabolic feature of coronary artery disease without traditional risk factors
- 31 Dec 2026
- Clinical and Experimental Hypertension
Inflammatory mechanisms and targeted drugs in heart failure
- 31 Dec 2026
- Clinical and Experimental Hypertension
Synergistic impact of nondipper heart rate and blood pressure on left ventricular hypertrophy in essential hypertension
- 31 Dec 2026
- Clinical and Experimental Hypertension
Dissecting burden of alcoholic cardiomyopathy: age-period-cohort analysis from the global burden of disease study 2019
- 31 Dec 2026
- Clinical and Experimental Hypertension
Frailty as a mediator of the association between hyperuricemia and stroke risk: A prospective cohort study.
- 31 Dec 2026
- Clinical and experimental hypertension (New York, N.Y. : 1993)
Bulk and single-cell transcriptomics for identification of potential diagnostic biomarkers associated with pulmonary arterial hypertension and integrated stress response and experimental validation
- 31 Dec 2026
- Clinical and Experimental Hypertension
Elevated circulating unsaturated fatty acids: A novel metabolic feature of coronary artery disease without traditional risk factors
- 31 Dec 2026
- Clinical and Experimental Hypertension
Inflammatory mechanisms and targeted drugs in heart failure
- 31 Dec 2026
- Clinical and Experimental Hypertension